Relating Dose of Contrast Media Administered to Uptake and Washout of Malignant Lesions on DCEMRI of the Breast

Academic Radiology

Volumn 17, Issue 1, 2010, Pages 24-30

  Jansen, Sanaz A ^a   Fan, Xiaobing ^a   Yang, Cheng ^a   Shimauchi, Akiko ^a   Karczmar, Gregory ^a   Newstead, Gillian M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

breast cancer; Breast MRI; contrast dose; kinetics

Indexed keywords

GADODIAMIDE;

ADULT; ARTICLE; BODY WEIGHT; BREAST LESION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

BREAST NEOPLASMS; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; METABOLIC CLEARANCE RATE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 71149093917     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2009.06.015     Document Type: Article

References (33)

1. Boetes C., Mus R.D., Holland R., et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197 (1995) 743-747
2. Schouten van der Velden A.P., Boetes C., Bult P., et al. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 192 (2006) 172-178
3. Liberman L. Breast MR imaging in assessing extent of disease. Magn Reson Imaging Clin N Am 14 (2006) 339-349 vi
4. Newstead G.M. MR imaging in the management of patients with breast cancer. Semin Ultrasound CT MR 27 (2006) 320-332
5. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89
6. Hylton N. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn Reson Imaging Clin N Am 14 (2006) 383-389 vii
7. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 211 (1999) 101-110
8. Abraham J.L., and Thakral C. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis. Eur J Radiol 66 (2008) 200-207
9. Kanal E., Barkovich A.J., Bell C., et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 188 (2007) 1447-1474
10. Heywang-Kobrunner S.H., Haustein J., Pohl C., et al. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 191 (1994) 639-646
11. Szabo B.K., Aspelin P., Wiberg M.K., et al. Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria. Acta Radiol 44 (2003) 379-386
12. Esserman L., Hylton N., George T., et al. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 5 (1999) 13-21
13. Li K.L., Partridge S.C., Joe B.N., et al. Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. Radiology 248 (2008) 79-87
14. Li K.L., Henry R.G., Wilmes L.J., et al. Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging. Magn Reson Med 58 (2007) 572-581
15. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 6 (1979) 65-70
16. Jansen S.A., Newstead G.M., Abe H., et al. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 245 (2007) 684-691
17. Schnall M.D., Blume J., Bluemke D.A., et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238 (2006) 42-53
18. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23 (2005) 8469-8476
19. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292 (2004) 1317-1325
20. Sardanelli F., Podo F., D'Agnolo G., et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 242 (2007) 698-715
21. Heywang-Kobrunner S.H., Bick U., Bradley Jr. W.G., et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 11 (2001) 531-546
22. Leach M.O., Boggis C.R., Dixon A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 (2005) 1769-1778
23. Knopp M.V., Bourne M.W., Sardanelli F., et al. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. AJR Am J Roentgenol 181 (2003) 663-676
24. Pediconi F., Catalano C., Occhiato R., et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 237 (2005) 45-56
25. FDA. Prohance, Available at: http://www.fda.gov/cder/foi/label/2007/020131s023,021489s001lbl.pdf. Accessed February 25, 2009.
26. FDA. Magnevist, Available at: http://www.fda.gov/cder/foi/label/2007/019596s043,021037s018lbl.pdf. Accessed February 25, 2009.
27. FDA. Omniscan, Available at: http://www.fda.gov/cder/foi/label/2007/020123s034lbl.pdf. Accessed February 25, 2009.
28. FDA. Multihance, Available at: http://www.fda.gov/cder/foi/label/2007/021357s003,021358s003lbl.pdf. Accessed February 25, 2009.
29. Warren R., Hayes C., Pointon L., et al. A test of performance of breast MRI interpretation in a multicentre screening study. Magn Reson Imaging 24 (2006) 917-929
30. Van Goethem M., Schelfout K., Kersschot E., et al. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. Jbr-Btr 88 (2005) 225-232
31. Neubauer H., Li M., Kuehne-Heid R., et al. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 76 (2003) 3-12
32. Chen W., Giger M.L., Bick U., et al. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. Med Phys 33 (2006) 2878-2887
33. Armitage P., Behrenbruch C., Brady M., and Moore N. Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast. Med Image Anal 9 (2005) 315-329